N.R. Cutler

2.0k total citations · 2 hit papers
34 papers, 1.6k citations indexed

About

N.R. Cutler is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology. According to data from OpenAlex, N.R. Cutler has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 6 papers in Physiology. Recurrent topics in N.R. Cutler's work include Migraine and Headache Studies (8 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Cardiovascular Syncope and Autonomic Disorders (4 papers). N.R. Cutler is often cited by papers focused on Migraine and Headache Studies (8 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Cardiovascular Syncope and Autonomic Disorders (4 papers). N.R. Cutler collaborates with scholars based in United States, Netherlands and Canada. N.R. Cutler's co-authors include С. И. Рапопорт, James V. Haxby, C. L. Grady, Ranjan Duara, Martin G. Larson, Leonard L. Heston, A. Moore, N. Schlageter, Magesh Sundaram and Serge Gauthier and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

N.R. Cutler

32 papers receiving 1.5k citations

Hit Papers

Effects of Xanomeline, a Selective Muscarinic Receptor Ag... 1986 2026 1999 2012 1997 1986 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
    1997 528 citations N. Bodick, Walter Offen et al. Archives of Neurology profile →
  2. Positron emission tomography in Alzheimer's disease
    1986 438 citations Ranjan Duara, C. L. Grady et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N.R. Cutler United States 16 631 505 494 443 229 34 1.6k
In‐Ho Paik South Korea 26 467 0.7× 422 0.8× 204 0.4× 272 0.6× 152 0.7× 61 1.7k
Robert Perry United Kingdom 14 436 0.7× 396 0.8× 388 0.8× 434 1.0× 396 1.7× 19 1.9k
Pierre Étienne Canada 25 357 0.6× 570 1.1× 516 1.0× 795 1.8× 410 1.8× 57 2.0k
F. Leblhuber Austria 18 284 0.5× 296 0.6× 371 0.8× 286 0.6× 104 0.5× 51 1.4k
Francesco Pisani Italy 32 2.1k 3.3× 367 0.7× 240 0.5× 728 1.6× 183 0.8× 132 3.5k
Tiffini Voss United States 16 591 0.9× 285 0.6× 903 1.8× 341 0.8× 387 1.7× 31 2.4k
Joseph F. Gardocki United States 18 619 1.0× 454 0.9× 190 0.4× 529 1.2× 246 1.1× 30 1.8k
Alberto Trequattrini Italy 17 662 1.0× 189 0.4× 322 0.7× 99 0.2× 87 0.4× 23 1.3k
Yu‐Li Liu Taiwan 26 280 0.4× 613 1.2× 178 0.4× 354 0.8× 205 0.9× 103 1.9k
Paul Ardayfio United States 14 452 0.7× 391 0.8× 920 1.9× 359 0.8× 336 1.5× 33 1.7k

Countries citing papers authored by N.R. Cutler

Since Specialization
Citations

This map shows the geographic impact of N.R. Cutler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.R. Cutler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.R. Cutler more than expected).

Fields of papers citing papers by N.R. Cutler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.R. Cutler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.R. Cutler. The network helps show where N.R. Cutler may publish in the future.

Co-authorship network of co-authors of N.R. Cutler

This figure shows the co-authorship network connecting the top 25 collaborators of N.R. Cutler. A scholar is included among the top collaborators of N.R. Cutler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.R. Cutler. N.R. Cutler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomez‐Mancilla, Baltazar, N.R. Cutler, Egilius L.H. Spierings, et al.. (2001). Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. Cephalalgia. 21(7). 727–732. 65 indexed citations
2.
Cutler, N.R., et al.. (2000). 529. Pharmacokinetics of rivastigmine and its metabolite in patients with Alzheimer’s disease. Biological Psychiatry. 47(8). S161–S161. 3 indexed citations
3.
Bodick, N., Walter Offen, Allan I. Levey, et al.. (1997). Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease. Archives of Neurology. 54(4). 465–473. 528 indexed citations breakdown →
4.
Cutler, N.R., et al.. (1997). Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin. Antimicrobial Agents and Chemotherapy. 41(6). 1298–1300. 23 indexed citations
5.
Hubble, Jean, William C. Koller, N.R. Cutler, et al.. (1995). Pramipexole in Patients with Early Parkinsonʼs Disease. Clinical Neuropharmacology. 18(4). 338–347. 115 indexed citations
6.
Mandos, Laura A., et al.. (1995). Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder. International Clinical Psychopharmacology. 10(4). 251–256. 8 indexed citations
7.
Sramek, John J., et al.. (1995). Anti-hypertensive effects of intravenous compared with oral captopril.. PubMed. 9(11). 875–8. 1 indexed citations
8.
Cutler, N.R., et al.. (1995). Tolerability and pharmacodynamics of besipirdine in Alzheimer's disease. Biological Psychiatry. 37(9). 643–643. 1 indexed citations
9.
Rapoport, Alan M., W. Hester Visser, N.R. Cutler, et al.. (1995). Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan. Neurology. 45(8). 1505–1509. 27 indexed citations
10.
Cutler, N.R., et al.. (1995). Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.. PubMed. 45(8 Suppl 7). S5–9. 54 indexed citations
11.
Sramek, John J., Allen H. Heller, P. R. Sundaresan, et al.. (1994). Safety and Tolerance of Intravenous Nimodipine. Annals of Pharmacotherapy. 28(10). 1143–1148. 4 indexed citations
12.
Cutler, N.R., et al.. (1994). Placebo-controlled study of a CCKB antagonist in patients with panic disorder. Biological Psychiatry. 35(9). 680–680. 3 indexed citations
13.
Cutler, N.R., et al.. (1994). Safety, tolerance, pharmacokinetic and RBC cholinesterase activity of MDL 73,745. Biological Psychiatry. 35(9). 680–680. 2 indexed citations
14.
Cutler, N.R., et al.. (1994). A bridging study of xanomeline tartrate in Alzheimer's disease (AD). Biological Psychiatry. 35(9). 628–628. 1 indexed citations
15.
Cutler, N.R., et al.. (1994). Maximally tolerated dose of the muscarinic agonist CI-979 in Alzheimer's disease (AD). Biological Psychiatry. 35(9). 628–628. 2 indexed citations
16.
Sramek, John J., et al.. (1992). Detection of Benzodiazepines in Human Hair by Radioimmunoassay. Annals of Pharmacotherapy. 26(4). 469–472. 34 indexed citations
17.
Cutler, N.R., et al.. (1992). MULTIPLE-DOSE SAFETY TOLERANCE OF L-693,487 (Heptylphysostigmine) IN ALZHEIMERʼS DISEASE (AD).. Clinical Neuropharmacology. 15. 468B–468B. 1 indexed citations
18.
Cutler, N.R., et al.. (1991). Oral Sumatriptan in Pharmacokinetics in the Migrainous State. Cephalalgia. 11(11_suppl). 222–223. 18 indexed citations
19.
Duara, Ranjan, C. L. Grady, James V. Haxby, et al.. (1986). Positron emission tomography in Alzheimer's disease. Neurology. 36(7). 879–879. 438 indexed citations breakdown →
20.
Cutler, N.R. & Jon F. Heiser. (1978). Retrospective diagnosis of hypomania following successful treatment of episodic violence with lithium: a case report. American Journal of Psychiatry. 135(6). 753–754. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by In‐Ho Paik Breakdown of academic impact, for papers by Robert Perry Breakdown of academic impact, for papers by Pierre Étienne Breakdown of academic impact, for papers by F. Leblhuber Breakdown of academic impact, for papers by Francesco Pisani Breakdown of academic impact, for papers by Tiffini Voss Breakdown of academic impact, for papers by Joseph F. Gardocki Breakdown of academic impact, for papers by Alberto Trequattrini Breakdown of academic impact, for papers by Yu‐Li Liu Breakdown of academic impact, for papers by Paul Ardayfio
Rankless by CCL
2026